S100A4 and cardiomyopathy: Finally, as mentioned when selecting the C6 subtype, we conducted in vitro experiments to determine whether the knockdown of S100A4 similarly blocks cell growth and promotes apoptosis in SMCs, with the aim of exploring its role in cardiomyopathy, particularly in ICM.